Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 38. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_1447ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineH226NANAXTT assayLog10 pfu/cell70% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1457ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (77.79 +/- 25.08 micromolar, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.543 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1463ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (77.79 +/- 25.08 micromolar, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.344NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1469ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (77.79 +/- 25.08 micromolar, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.218NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1475ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (77.79 +/- 25.08 micromolar, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.004 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1481ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (77.79 +/- 25.08 micromolar, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 1 × 10⁴ NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1487ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (77.79 +/- 25.08 micromolar, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 4 × 10⁶ NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1493ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (14.71+/- 6.60, ratio is 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.615NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1499ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (14.71+/- 6.60, ratio is 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.297NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1505ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (14.71+/- 6.60, ratio is 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.145NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1511ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (14.71+/- 6.60, ratio is 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.558NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1517ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (14.71+/- 6.60, ratio is 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.057NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1523ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (14.71+/- 6.60, ratio is 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.013NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1529ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (17.69+/- 10.16, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.112NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1535ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (17.69+/- 10.16, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75 % cell death at CI 0.030NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1541ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (17.69+/- 10.16, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.008NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1547ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (17.69+/- 10.16, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.057NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1553ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (17.69+/- 10.16, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.007NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1559ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (17.69+/- 10.16, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.001NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1565ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(28.46+/-14.13, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.081NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1571ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(28.46+/-14.13, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.043NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1577ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(28.46+/-14.13, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.023NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1583ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(28.46+/-14.13, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.027NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1589ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(28.46+/-14.13, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.006NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1595ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(28.46+/-14.13, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.001NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_4984AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaH2261.0E+4 cells per wellNAMTS assay10 VP per cell90% cell viability after 72 hoursNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4985AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFNoVirus in combination with drugs pemetrexed 0.0026 mg/ml + cisplatin 0.0625Virus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaH2261.0E+4 cells per wellNAMTS assay10 VP per cell70% cell viability after 72 hoursNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4986AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFNoVirus in combination with drugs pemetrexed 0.0026 mg/ml + carboplatin 0.0625Virus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaH2261.0E+4 cells per wellNAMTS assay10 VP per cell72% cell viability after 72 hoursNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4994AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaH2261.0E+4 cells per wellNAMTS assay1 VP per cell100% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4995AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaH2261.0E+4 cells per wellNAMTS assay10 VP per cell90% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4996AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaH2261.0E+4 cells per wellNAMTS assay100 VP per cell40% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_4997AdenovirusONCOS-102DNAAdenoviridaeVirus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSFYesNoVirus expressing human GM-CSF geneDSMZ GermanyHuman epitheliod mesotheliomaH2261.0E+4 cells per wellNAMTS assay1000 VP per cell20% cell viability after 3 daysNoNoNA No responseNAVirus induce apoptosisNANA27287512
OV_5237Paroviruswild typeDNAParoviridaeNoneYesNoNoATCCHuman mesothelioma cell lineNCI-H2265.0E+3 cells per wellNAMTS assay10 VP per cell10% cell viableNoNoNA No responseNANANANA27783867
OV_5238Paroviruswild typeDNAParoviridaeNoneYesNoNoATCCHuman mesothelioma cell lineNCI-H2265.0E+3 cells per wellNAMTS assay100 VP per cell2% cell viableNoNoNA No responseNANANANA27783867
OV_5239Paroviruswild typeDNAParoviridaeNoneYesNoNoATCCHuman mesothelioma cell lineNCI-H2265.0E+3 cells per wellNAMTS assay1000 VP per cell100% cell killingNoNoNA No responseNANANANA27783867
OV_5249ParovirusAd5/3VEGFE1-deltaDNAParoviridaeDeletion mutant for E1A gene and expressing VEGF geneYesNoNoATCCHuman mesothelioma cell lineNCI-H2265.0E+3 cells per wellNAMTS assay10 VP per cell10% cell viableNoNoNA No responseNANANANA27783867
OV_5250ParovirusAd5/3VEGFE1-deltaDNAParoviridaeDeletion mutant for E1A gene and expressing VEGF geneYesNoNoATCCHuman mesothelioma cell lineNCI-H2265.0E+3 cells per wellNAMTS assay100 VP per cell5 % cell viableNoNoNA No responseNANANANA27783867
OV_5251ParovirusAd5/3VEGFE1-deltaDNAParoviridaeDeletion mutant for E1A gene and expressing VEGF geneYesNoNoATCCHuman mesothelioma cell lineNCI-H2265.0E+3 cells per wellNAMTS assay1000 VP per cell100% cell killingNoNoNA No responseNANANANA27783867